Frontiers in public health
-
Front Public Health · Jan 2020
Integrating Air Quality and Public Health Benefits in U.S. Decarbonization Strategies.
Research on air quality and human health "co-benefits" from climate mitigation strategies represents a growing area of policy-relevant scholarship. Compared to other aspects of climate and energy policy evaluation, however, there are still relatively few of these co-benefits analyses. This sparsity reflects a historical disconnect between research quantifying energy and climate, and research dealing with air quality and health. ⋯ Studies in the peer-reviewed literature (n = 26) have evaluated carbon pricing, renewable portfolio standards, energy efficiency, renewable energy deployment, and clean transportation. A number of major findings have emerged from these studies: [1] decarbonization strategies can reduce air pollution disproportionally on the most polluted days; [2] renewable energy deployment and climate policies offer the highest health and economic benefits in regions with greater reliance on coal generation; [3] monetized air quality health co-benefits can offset costs of climate policy implementation; [4] monetized co-benefits typically exceed the levelized cost of electricity (LCOE) of renewable energies; [5] Electric vehicle (EV) adoption generally improves air quality on peak pollution days, but can result in ozone dis-benefits in urban centers due to the titration of ozone with nitrogen oxides. Drawing from these published studies, we review the state of knowledge on climate co-benefits to air quality and health, identifying opportunities for policy action and further research.
-
Front Public Health · Jan 2020
ReviewSevere COVID-19: A Review of Recent Progress With a Look Toward the Future.
The novel coronavirus disease 2019 (COVID-19) is an acute infectious disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, the World Health Organization has confirmed that COVID-19 is a global infectious disease pandemic. This is the third acute infectious disease caused by coronavirus infection in this century, after sudden acute respirator syndrome and Middle East respiratory syndrome. ⋯ Currently, there are no specific antiviral drugs for the treatment of COVID-19. Most patients need to be admitted to the intensive care unit for intensive monitoring and supportive organ function treatments. This article reviews the epidemiology, pathogenesis, clinical manifestations, diagnosis, and treatment methods of severe COVID-19 and puts forward some tentative ideas, aiming to provide some guidance for the diagnosis and treatment of severe COVID-19.
-
Front Public Health · Jan 2020
ReviewRole of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know.
The outbreak of the current 2019 novel coronavirus (2019-nCoV, now named SARS-CoV-2) infection has become a worldwide health threat. Currently, more information is needed so as to further understand the transmission and clinical characteristics of 2019-nCoV infection and the infection control procedures required. Recently, the role of the eye in transmitting 2019-nCoV has been intensively discussed. ⋯ This suggests that the eye is neither a preferred organ of human CoV infection nor a preferred gateway of entry for human CoVs for infecting the respiratory tract. However, pathogens that the ocular surface is exposed to might be transported to nasal and nasopharyngeal mucosa by constant tear rinsing through the lacrimal duct system and then cause respiratory tract infection. Considering that close doctor-patient contact is quite common in ophthalmic practice and is apt to transmit human CoVs by droplets and fomites, strict hand hygiene and proper personal protection are highly recommended for health care workers to avoid hospital-related viral transmission during ophthalmic practice.
-
Front Public Health · Jan 2020
ReviewProgress in the Research and Development of Anti-COVID-19 Drugs.
The outbreaks of COVID-19 due to SARS-CoV-2 has caused serious physical and psychological damage to global human health. COVID-19 spread rapidly around the world in a short time. Confronted with such a highly infectious respiratory disease, the research and development of anti-COVID-19 drugs became an urgent work due to the lack of specific drugs for the treatment of COVID-19. ⋯ We reviewed information on selected anti-SARS-CoV-2 candidate therapeutic agents published until June 2, 2020. We also discussed the strategies of the development of anti-COVID-19 drugs in the future. Our review provides a novel insight into the future development of a safer, efficient, and toxic-less anti-COVID-19 drug.
-
Front Public Health · Jan 2020
Comparative StudyHow Does Public Knowledge, Attitudes, and Behaviors Correlate in Relation to COVID-19? A Community-Based Cross-Sectional Study in Nepal.
Background: The COVID-19 pandemic has created a global health emergency requiring an effective public health response including citizen's roles in preventing spread and controlling the pandemic. Little is known about public knowledge, beliefs and behaviors in-relation to the pandemic in Nepal. This study aims to assess knowledge, attitude and practices (KAP) toward COVID-19 among the general public and to identify associated factors. ⋯ Conclusion: The study found varying degrees of correlation between Knowledge, Attitude and Practice that may increase as the pandemic evolves in Nepal. Knowledge and level of education had positive associations with attitude and adherence to precautionary measures. The findings suggest a need for targeted community awareness interventions for the most vulnerable populations, men, those with no school education, the elderly and people living in rural areas.